25244-68-2Relevant articles and documents
Rapid N-alkylation of carbazole, phenothiazine and acridone under microwave irradiation
Fan, Xingjun,You, Jinmao,Jiao, Tianquan,Tan, Ganzu,Yu, Xianda
, p. 284 - 287 (2000)
-
Synthesis of Novel β-Lactams from Phenothiazin-10-ylacetic Acid
Omidvari, Zahra,Zarei, Maaroof
, p. 1085 - 1091 (2018)
The first synthesis of 3-phenothiazine-β-lactams is herein reported. Thirteen new derivatives of β-lactams were synthesized using various Schiff bases and (phenothiazin-10-yl)acetic acid, which in turn was prepared starting from phenothiazine. The sole product of the Staudinger ketene–imine [2?+?2] cycloaddition reaction is the trans-β-lactam. All the synthesized compounds were characterized by elemental analyses and spectral (IR, 1H-NMR, and 13C-NMR) data.
N of a kind of preparation method of-carbencillin methyl phenothiazine
-
Paragraph 0032-0060, (2019/02/02)
The invention relates to a method for preparing N-carboxymethyl phenothiazine, which comprises the following steps: directly mixing phenothiazine, potassium chloroacetate and N,N-dimethyl formamide, and heating while adjusting the pH value to 8-9; cooling the reaction liquid and adjusting to strong acidity, and adding the solution into water to obtain a product. According to the method provided by the invention, phenothiazine and potassium chloroacetate are used as raw materials, the product is synthesized by one step, the reaction time is short, the reaction process is simple, and the operation is easy; moreover, the conversion rate of the raw materials is very high, the yield of the obtained product exceeds 95%, and the new design thought provides more application space for the synthesis of N-carboxymethyl phenothiazine.
INHIBITORS OF MALT1 PROTEASE
-
Page/Page column 80, (2014/06/24)
The present invention relates to compounds which are inhibitors of mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALTl) and to their use in therapy, in particular in the treatment or prevention of a disease or disorder which is treatable by an inhibitor of a paracaspase. The present invention also relates to pharmaceutical compositions containing such compounds.